Therapeutic Drug Monitoring and Pharmacokinetics-Based Individualization of Drug Therapy

Contributors: Vasarhelyi, Barna, Karvaly, Gellért Balázs

Subject Terms: ganciclovir, lung transplant recipients, cystic fibrosis, therapeutic drug monitoring, covariates, haloperidol, pharmacokinetics, delirium, critical ill, ICU, dapagliflozin, linagliptin, fixed-dose combination products, bioequivalence, busulfan, sulfolane, myelofibrosis, population pharmacokinetics, heart transplantation, acute rejection, tacrolimus, endomyocardial biopsies, pharmacokinetic interactions, heart transplant, precision medicine, clinical practice, gentamicin, population pharmacokinetic modeling, external evaluation, model re-estimation, dosing nomogram, long-acting antiretroviral therapy, cabotegravir, rilpivirine, pharmacokinetic simulation, TDM, plasma level, PK/PD, dose–effect relationship, LC–MS/MS, CFTR modulators, caftor, ivacaftor, lumacaftor, tezacaftor, elexacaftor, population pharmacokinetic, rivaroxaban, atrial fibrillation, direct oral anticoagulants, Thai patient, tobramycin, model-informed precision dosing, dalbavancin, long-acting, Gram-positive, osteoarticular infections, laparoscopic sleeve gastrectomy, omeprazole, modeling and simulation, obesity, treatment efficacy, medication adherence, schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, depressive disorder, cefiderocol, antibiotics, drug monitoring, isavuconazole, pediatric, pharmacodynamics, Bayesian, fungal infection, outcomes, oral anticancer drugs, oncology, imatinib, precision pharmacotherapy, cerebrospinal fluid, methotrexate, children, acute lymphoid leukemia, external validation, non-infectious uveitis (NIU), therapeutic drug monitoring (TDM), pharmacogenetics, biological therapy, limited sampling strategies, population pharmacokinetic modelling, semi-parametric simulation, robustness, area under the curve, AUC, glomerular filtration rate, GFR, tuberculosis, rifampicin, dried blood spots, limited-sampling strategy, pharmacokinetic boosting, pharmacokinetic enhancement, ritonavir, cobicistat, kinase inhibitors, small molecule kinase inhibitors, critical illness, sepsis, kidney injury, biomarkers, pediatric pharmacology, Bayesian estimation, piperacillin, tazobactam, nonparametric adaptive grid, Bayesian models, intensive care, Medicine and Nursing, Pharmacology

File Description: application/octet-stream

Access URL: https://directory.doabooks.org/handle/20.500.12854/143737
https://mdpi.com/books/pdfview/book/9781

Evaluation of limited-sampling strategies to calculate AUC(0–24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus

Authors: Carla Galvez, Pía Boza, Mariluz González, Catalina Hormazabal, Marlene Encina, Manuel Azócar, Luis E. Castañeda, Angélica Rojo, María Luisa Ceballos, Paola Krall

Source: Frontiers in Pharmacology, Vol 14 (2023)

Subject Terms: pediatric kidney transplant, tacrolimus, limited sampling strategies, area under a curve (AUC), CYP3A5, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1044050/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/3c096cc401114927a90c3cd4f2278ec3

A Method for Evaluating Robustness of Limited Sampling Strategies—Exemplified by Serum Iohexol Clearance for Determination of Measured Glomerular Filtration Rate

Authors: Markus Hovd, Ida Robertsen, Jean-Baptiste Woillard, Anders Åsberg

Source: Pharmaceutics, Vol 15, Iss 4, p 1073 (2023)

Subject Terms: limited sampling strategies, population pharmacokinetic modelling, semi-parametric simulation, robustness, therapeutic drug monitoring, area under the curve, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: https://www.mdpi.com/1999-4923/15/4/1073; https://doaj.org/toc/1999-4923

Access URL: https://doaj.org/article/02e181529a1d41aa9c231317ab6f91c3

Optimal Sampling Times in Population Pharmacokinetic Studies

Authors: Stroud, Jonathan R., Muller, Peter, Rosner, Gary L.

Source: Journal of the Royal Statistical Society. Series C (Applied Statistics), 2001 Jan 01. 50(3), 345-359.

Access URL: https://www.jstor.org/stable/2680875

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.